DRA Uges

564 total citations
8 papers, 294 citations indexed

About

DRA Uges is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, DRA Uges has authored 8 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in DRA Uges's work include Drug Transport and Resistance Mechanisms (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Cancer therapeutics and mechanisms (2 papers). DRA Uges is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Cancer therapeutics and mechanisms (2 papers). DRA Uges collaborates with scholars based in Netherlands and United States. DRA Uges's co-authors include Elisabeth G.E. de Vries, NH Mulder, Coby Meijer, Geke A.P. Hospers, Willy Lemstra, W.J. Sluiter, Phb Willemse, Harm H. Kampinga, Hetty Timmer‐Bosscha and D.Th. Sleijfer and has published in prestigious journals such as The Lancet, British Journal of Cancer and PubMed.

In The Last Decade

DRA Uges

8 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
DRA Uges Netherlands	7	152	124	65	52	45	8	294
Sachie Tanno Japan	10	262 1.7×	186 1.5×	89 1.4×	64 1.2×	57 1.3×	16	489
Anna Apicella Italy	10	125 0.8×	115 0.9×	39 0.6×	34 0.7×	19 0.4×	16	357
Howell Sb United States	8	218 1.4×	258 2.1×	40 0.6×	78 1.5×	49 1.1×	10	456
Masami Bungo Japan	7	264 1.7×	242 2.0×	27 0.4×	53 1.0×	15 0.3×	10	396
Salah T. Fayed Egypt	8	120 0.8×	111 0.9×	29 0.4×	21 0.4×	84 1.9×	16	337
Michael S. Stahler United States	9	171 1.1×	136 1.1×	99 1.5×	24 0.5×	159 3.5×	16	454
Keith Moser Austria	10	121 0.8×	133 1.1×	26 0.4×	30 0.6×	7 0.2×	80	358
Yu-Chieh Lee Taiwan	11	225 1.5×	54 0.4×	23 0.4×	20 0.4×	23 0.5×	14	370
Samar Masoumi Moghaddam Australia	5	185 1.2×	102 0.8×	30 0.5×	33 0.6×	64 1.4×	6	323
Andrea Piée‐Staffa Germany	9	244 1.6×	98 0.8×	41 0.6×	33 0.6×	10 0.2×	11	329

Countries citing papers authored by DRA Uges

Since Specialization

Citations

This map shows the geographic impact of DRA Uges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DRA Uges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DRA Uges more than expected).

Fields of papers citing papers by DRA Uges

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DRA Uges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DRA Uges. The network helps show where DRA Uges may publish in the future.

Co-authorship network of co-authors of DRA Uges

This figure shows the co-authorship network connecting the top 25 collaborators of DRA Uges. A scholar is included among the top collaborators of DRA Uges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DRA Uges. DRA Uges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Mulder, NH, DRA Uges, Sanjeev Kaul, et al.. (1997). Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide. British Journal of Cancer. 75(11). 1660–1666. 21 indexed citations

2.

Lemstra, Willy, et al.. (1997). Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells. British Journal of Cancer. 75(12). 1735–1743. 46 indexed citations

3.

Timmer‐Bosscha, Hetty, Coby Meijer, DRA Uges, et al.. (1995). Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines. British Journal of Cancer. 71(4). 684–690. 49 indexed citations

4.

Gietema, Jourik A., G.J. Veldhuis, Henk‐Jan Guchelaar, et al.. (1995). Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer. British Journal of Cancer. 71(6). 1302–1307. 44 indexed citations

5.

Vries, Elisabeth G.E. de, et al.. (1990). Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days. British Journal of Cancer. 61(3). 460–464. 17 indexed citations

6.

Meijer, Coby, NH Mulder, Geke A.P. Hospers, DRA Uges, & Elisabeth G.E. de Vries. (1990). The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. British Journal of Cancer. 62(1). 72–77. 108 indexed citations

7.

Sleijfer, D.Th., et al.. (1987). Phase I and pharmacokinetic study of trans-N3P3Az2(NHMe)4.. PubMed. 71(2). 155–9. 1 indexed citations

8.

Uges, DRA. (1986). UNITS FOR THERAPEUTIC DRUG-MONITORING TOXICOLOGY. The Lancet. 1(8487). 979–980. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact